vs

Side-by-side financial comparison of Energy Services of America CORP (ESOA) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Energy Services of America CORP is the larger business by last-quarter revenue ($114.1M vs $74.7M, roughly 1.5× Health Catalyst, Inc.). On growth, Energy Services of America CORP posted the faster year-over-year revenue change (13.4% vs -6.2%). Energy Services of America CORP produced more free cash flow last quarter ($16.8M vs $9.6M). Over the past eight quarters, Energy Services of America CORP's revenue compounded faster (26.7% CAGR vs -0.0%).

Superior Energy Services is an American oil services company that operates as a holding company for a portfolio of oilfield equipment rentals and well oil and gas services brands.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

ESOA vs HCAT — Head-to-Head

Bigger by revenue
ESOA
ESOA
1.5× larger
ESOA
$114.1M
$74.7M
HCAT
Growing faster (revenue YoY)
ESOA
ESOA
+19.6% gap
ESOA
13.4%
-6.2%
HCAT
More free cash flow
ESOA
ESOA
$7.1M more FCF
ESOA
$16.8M
$9.6M
HCAT
Faster 2-yr revenue CAGR
ESOA
ESOA
Annualised
ESOA
26.7%
-0.0%
HCAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ESOA
ESOA
HCAT
HCAT
Revenue
$114.1M
$74.7M
Net Profit
$-91.0M
Gross Margin
12.3%
Operating Margin
4.3%
-115.3%
Net Margin
-121.9%
Revenue YoY
13.4%
-6.2%
Net Profit YoY
-340.3%
EPS (diluted)
$0.16
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESOA
ESOA
HCAT
HCAT
Q4 25
$114.1M
$74.7M
Q3 25
$130.1M
$76.3M
Q2 25
$103.6M
$80.7M
Q1 25
$76.7M
$79.4M
Q4 24
$100.6M
$79.6M
Q3 24
$104.7M
$76.4M
Q2 24
$85.9M
$75.9M
Q1 24
$71.1M
$74.7M
Net Profit
ESOA
ESOA
HCAT
HCAT
Q4 25
$-91.0M
Q3 25
$-22.2M
Q2 25
$-41.0M
Q1 25
$-23.7M
Q4 24
$-20.7M
Q3 24
$-14.7M
Q2 24
$-13.5M
Q1 24
$-20.6M
Gross Margin
ESOA
ESOA
HCAT
HCAT
Q4 25
12.3%
Q3 25
12.6%
52.6%
Q2 25
11.6%
Q1 25
0.1%
Q4 24
10.2%
Q3 24
16.8%
47.5%
Q2 24
17.8%
Q1 24
8.8%
Operating Margin
ESOA
ESOA
HCAT
HCAT
Q4 25
4.3%
-115.3%
Q3 25
5.8%
-22.9%
Q2 25
3.1%
-46.0%
Q1 25
-10.6%
-25.4%
Q4 24
1.6%
-22.0%
Q3 24
8.4%
-17.9%
Q2 24
9.9%
-20.8%
Q1 24
-1.5%
-30.5%
Net Margin
ESOA
ESOA
HCAT
HCAT
Q4 25
-121.9%
Q3 25
-29.1%
Q2 25
-50.8%
Q1 25
-29.9%
Q4 24
-26.0%
Q3 24
-19.3%
Q2 24
-17.8%
Q1 24
-27.6%
EPS (diluted)
ESOA
ESOA
HCAT
HCAT
Q4 25
$0.16
$-1.29
Q3 25
$0.26
$-0.32
Q2 25
$0.12
$-0.59
Q1 25
$-0.41
$-0.35
Q4 24
$0.05
$-0.33
Q3 24
$0.40
$-0.24
Q2 24
$1.06
$-0.23
Q1 24
$-0.07
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESOA
ESOA
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$16.7M
$95.7M
Total DebtLower is stronger
$62.0M
$153.3M
Stockholders' EquityBook value
$60.6M
$245.8M
Total Assets
$201.0M
$502.6M
Debt / EquityLower = less leverage
1.02×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESOA
ESOA
HCAT
HCAT
Q4 25
$16.7M
$95.7M
Q3 25
$12.2M
$91.5M
Q2 25
$15.3M
$97.3M
Q1 25
$9.9M
$342.0M
Q4 24
$20.3M
$392.0M
Q3 24
$12.9M
$387.3M
Q2 24
$14.5M
$308.3M
Q1 24
$12.1M
$327.8M
Total Debt
ESOA
ESOA
HCAT
HCAT
Q4 25
$62.0M
$153.3M
Q3 25
$72.2M
$153.1M
Q2 25
$59.1M
$153.0M
Q1 25
$50.7M
$382.9M
Q4 24
$59.6M
$382.4M
Q3 24
$33.9M
$345.0M
Q2 24
$31.9M
Q1 24
$45.7M
Stockholders' Equity
ESOA
ESOA
HCAT
HCAT
Q4 25
$60.6M
$245.8M
Q3 25
$59.2M
$331.9M
Q2 25
$54.4M
$347.5M
Q1 25
$53.7M
$376.8M
Q4 24
$61.0M
$365.2M
Q3 24
$58.7M
$355.0M
Q2 24
$52.0M
$357.0M
Q1 24
$34.6M
$357.2M
Total Assets
ESOA
ESOA
HCAT
HCAT
Q4 25
$201.0M
$502.6M
Q3 25
$215.2M
$587.1M
Q2 25
$189.1M
$616.2M
Q1 25
$170.2M
$891.5M
Q4 24
$192.1M
$858.9M
Q3 24
$158.2M
$813.0M
Q2 24
$148.8M
$691.7M
Q1 24
$136.1M
$695.1M
Debt / Equity
ESOA
ESOA
HCAT
HCAT
Q4 25
1.02×
0.62×
Q3 25
1.22×
0.46×
Q2 25
1.09×
0.44×
Q1 25
0.94×
1.02×
Q4 24
0.98×
1.05×
Q3 24
0.58×
0.97×
Q2 24
0.61×
Q1 24
1.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESOA
ESOA
HCAT
HCAT
Operating Cash FlowLast quarter
$18.8M
$9.9M
Free Cash FlowOCF − Capex
$16.8M
$9.6M
FCF MarginFCF / Revenue
14.7%
12.9%
Capex IntensityCapex / Revenue
1.8%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.1M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESOA
ESOA
HCAT
HCAT
Q4 25
$18.8M
$9.9M
Q3 25
$-9.3M
$-464.0K
Q2 25
$3.4M
$-9.0M
Q1 25
$1.1M
$280.0K
Q4 24
$8.9M
$-3.5M
Q3 24
$-847.5K
$6.2M
Q2 24
$19.3M
$1.6M
Q1 24
$-2.7M
$10.3M
Free Cash Flow
ESOA
ESOA
HCAT
HCAT
Q4 25
$16.8M
$9.6M
Q3 25
$-12.0M
$-719.0K
Q2 25
$-582.0K
$-9.2M
Q1 25
$-1.1M
$-390.0K
Q4 24
$6.0M
$-3.9M
Q3 24
$-2.9M
$5.5M
Q2 24
$16.3M
$1.3M
Q1 24
$-4.9M
$10.1M
FCF Margin
ESOA
ESOA
HCAT
HCAT
Q4 25
14.7%
12.9%
Q3 25
-9.3%
-0.9%
Q2 25
-0.6%
-11.4%
Q1 25
-1.4%
-0.5%
Q4 24
5.9%
-4.9%
Q3 24
-2.8%
7.2%
Q2 24
18.9%
1.7%
Q1 24
-6.9%
13.5%
Capex Intensity
ESOA
ESOA
HCAT
HCAT
Q4 25
1.8%
0.4%
Q3 25
2.1%
0.3%
Q2 25
3.9%
0.3%
Q1 25
2.9%
0.8%
Q4 24
2.9%
0.5%
Q3 24
2.0%
0.9%
Q2 24
3.6%
0.4%
Q1 24
3.1%
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESOA
ESOA

Electricals Mechanical And General$49.4M43%
Gas And Petroleum Transmission$24.1M21%
Cost Plus And TM Contracts$23.3M20%
Transferred At Point In Time$17.9M16%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons